Dr. Schade is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 Ne Pacific St
Seattle, WA 98195Phone+1 206-598-4294
Summary
- I am a board certified urologist specializing in urologic oncology.
Education & Training
University of Washington School of MedicineFellowship, Minimally Invasive Urologic Surgery, 2013 - 2015- University of MichiganResidency, Urology, 2008 - 2013
- University of Michigan Health SystemInternship, Transitional Year, 2007 - 2008
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007
- University of ChicagoBA, Biology, General Honors, 1999 - 2003
Certifications & Licensure
WA State Medical License 2013 - 2025
MI State Medical License 2007 - 2013
American Board of Urology Urology
Awards, Honors, & Recognition
- Research Scholar Urology Care Foundation, 2015
Clinical Trials
- Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy Start of enrollment: 2015 Apr 22
Publications & Presentations
PubMed
- New kids on the block: MRI guided transrectal focused US, TULSA, focal laser ablation, histotripsy - a comprehensive review.Sangeet Ghai, Tiffany T Ni, Christian P Pavlovich, Jurgen J Futterer, George R Schade
Prostate Cancer and Prostatic Diseases. 2025-03-27 - Refining partial gland ablation for localised prostate cancer: the FALCON project.Lara Rodriguez-Sanchez, Xavier Cathelineau, Theo M de Reijke, Phillip Stricker, Mark Emberton
BJU International. 2025-02-04 - 1 citationsCharacterizing Psychological Resources and Resilience in Patients With Bladder Cancer: Associations With Frailty and Quality of Life.Erin Petersen, Sarah Holt, Anne Browning, Dana Cavanaugh, Samia Jannat
The Journal of Urology. 2025-01-01
Authored Content
- Does the Diagnosis of Bladder Cancer Lead to Higher Rates of Smoking Cessation? Findings from the Medicare Health Outcomes SurveyMarch 2019
Press Mentions
What 5 Doctors Are Excited About in Kidney Cancer ResearchSeptember 5th, 2024- EDAP Announces University of Washington Medicine to Launch Focal One® Robotic HIFU ProgramSeptember 28th, 2021
Grant Support
- Transrectal Histotripsy for Focal Ablation of Prostate CancerUNIVERSITY OF WASHINGTON2022–2027
- Noninvasive histotripsy ablation of fibrotic tissue in benign prostatic hyperplasiaUNIVERSITY OF WASHINGTON2019–2025
- Strategies in therapeutic ultrasound for predicting in situ fields and quantifying the impact of tissue inhomogeneitiesNIBIB2018–2021
- Metrology and Nonlinear Acoustics Bioeffects of High Intensity Focused UltrasoundNIBIB2017–2021
- FOCAL THERAPY OF PROSTATE CANCER USING NON-THERMAL TUMOR ABLATION WITH FOCUSED ULTRASOUNDNCI2017–2020
- Evaluation of the Systemic Response to Boiling Histotripsy Treatment for Renal CarcinomaFocused Ultrasound Surgery Foundation2015–2017
- Boiling Histotripsy of the Kidney: A Novel Ultrasound Based Treatment for Renal Cell CarcinomaUrology Care Foundation2015–2016
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
